166 related articles for article (PubMed ID: 32750728)
21. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
22. Computer Tomography (CT)-based Screening of Hospitalized Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease Complicated by Bronchiectasis Phenotype During Acute Exacerbation: A Clinical Analysis.
Zhao J; Wu Y; Zhang K; Zhang H; Ren H; Wang Y
Curr Med Imaging; 2023 May; ():. PubMed ID: 37157216
[TBL] [Abstract][Full Text] [Related]
23. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
[TBL] [Abstract][Full Text] [Related]
24. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
25. High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk.
Kwok WC; Teo KC; Lau KK; Ho JC
BMC Pulm Med; 2024 Feb; 24(1):80. PubMed ID: 38350918
[TBL] [Abstract][Full Text] [Related]
26. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
27. Does bronchiectasis affect COPD comorbidities?
Nowiński A; Korzybski D; Bednarek M; Goljan-Geremek A; Puścińska E; Śliwiński P
Adv Respir Med; 2019; 87(6):214-220. PubMed ID: 31970723
[TBL] [Abstract][Full Text] [Related]
28. Exacerbations in COPD Patients with Bronchiectasis.
Minov J; Stoleski S; Mijakoski D; Vasilevska K; Atanasovska A
Med Sci (Basel); 2017 Apr; 5(2):. PubMed ID: 29099023
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of Bronchiectasis Associated with Chronic Obstructive Pulmonary Disease.
Deghdegh K; Boukadoum N; Terra B; Amoura K; Benali R
Open Respir Med J; 2022; 16():e187430642203311. PubMed ID: 37273954
[TBL] [Abstract][Full Text] [Related]
30. Inflammation and chronic colonization of
Tufvesson E; Markstad H; Bozovic G; Ekberg M; Bjermer L
Int J Chron Obstruct Pulmon Dis; 2017; 12():3211-3219. PubMed ID: 29138549
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of symptoms and risks in stable chronic obstructive pulmonary disease patients with radiographic bronchiectasis.
Zhang RB; Yuan F; Tan XY; He QY
Chronic Dis Transl Med; 2017 Sep; 3(3):176-180. PubMed ID: 29063074
[TBL] [Abstract][Full Text] [Related]
32. Clinical Features of Patients with Bronchiectasis with Comorbid Chronic Obstructive Pulmonary Disease in China.
Xie C; Wen Y; Zhao Y; Zeng S; Guo Q; Liang Q; Chen L; Liu Y; Qiu F; Yang L; Lu J
Med Sci Monit; 2019 Sep; 25():6805-6811. PubMed ID: 31503552
[TBL] [Abstract][Full Text] [Related]
33. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
34. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
35. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
[TBL] [Abstract][Full Text] [Related]
36. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
[TBL] [Abstract][Full Text] [Related]
37. Relationship between serum γ-glutamyltransferase levels and acute exacerbation of chronic obstructive pulmonary disease.
Ermis H; Celik MR; Gulbas G; Tavli D; Aytemur ZA
Pol Arch Med Wewn; 2013; 123(3):85-90. PubMed ID: 23344614
[TBL] [Abstract][Full Text] [Related]
38. Fibrinogen: A Feasible Biomarker in Identifying the Severity and Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mohan M; Parthasarathi A; S K C; Biligere Siddaiah J; Mahesh PA
Cureus; 2021 Aug; 13(8):e16864. PubMed ID: 34367840
[TBL] [Abstract][Full Text] [Related]
39. Differences of viral panel positive versus negative by real-time PCR in COPD exacerbated patients.
Yormaz B; Fındık D; Süerdem M
Tuberk Toraks; 2019 Jun; 67(2):124-130. PubMed ID: 31414643
[TBL] [Abstract][Full Text] [Related]
40. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Wang RT; Li JY; Cao ZG; Li Y
Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
